Comparison between Goldline Pharmaceutical IPO and Highness Microelectronics IPO.
Goldline Pharmaceutical IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Highness Microelectronics IPO is a SME Bookbuilding proposed to list at BSE SME.
| Goldline Pharmaceutical IPO | Highness Microelectronics IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Cumulative Capital Pvt.Ltd. | Fintellectual Corporate Advisors Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | Nirman Share Brokers Pvt.Ltd. | Rainbow Securities Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Goldline Pharmaceutical IPO is up to ₹11.02 Cr whereas the issue size of the Highness Microelectronics IPO is up to ₹20.58 Cr. The final issue price of Goldline Pharmaceutical IPO is ₹43.00 per share and of Highness Microelectronics IPO is ₹120.00 per share.
| Goldline Pharmaceutical IPO | Highness Microelectronics IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹41.00 per share | ₹114.00 per share |
| Issue Price (Upper) | ₹43.00 per share | ₹120.00 per share |
| Issue Price (Final) | ₹43.00 per share | ₹120.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 3000 shares | 1200 shares |
| Fresh Issue Size | 25,62,000 shares | 15,62,400 shares |
| Fresh Issue Size (Amount) | up to ₹11.02 Cr | up to ₹18.75 Cr |
| OFS Issue Size | 0 shares | 1,52,400 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹1.83 Cr |
| Issue Size Total | 25,62,000 shares | 17,14,800 shares |
| Issue Size Total (Amount) | up to ₹11.02 Cr | up to ₹20.58 Cr |
Goldline Pharmaceutical IPO opens on May 12, 2026, while Highness Microelectronics IPO opens on Mar 24, 2026. The closing date of Goldline Pharmaceutical IPO and Highness Microelectronics IPO is May 14, 2026, and Mar 27, 2026, respectively.
| Goldline Pharmaceutical IPO | Highness Microelectronics IPO | |
|---|---|---|
| Anchor Bid Date | May 11, 2026 | Mar 23, 2026 |
| Issue Open | May 12, 2026 | Mar 24, 2026 |
| Issue Close | May 14, 2026 | Mar 27, 2026 |
| Basis Of Allotment (Tentative) | May 15, 2026 | Mar 30, 2026 |
| Initiation of Refunds (Tentative) | May 18, 2026 | Apr 01, 2026 |
| Credit of Share (Tentative) | May 18, 2026 | Apr 01, 2026 |
| Listing date (Tentative) | May 19, 2026 | Apr 02, 2026 |
| Anchor Lockin End date 1 | Jun 14, 2026 | May 01, 2026 |
| Anchor Lockin End date 2 | Aug 13, 2026 | Jun 30, 2026 |
Goldline Pharmaceutical IPO P/E ratio is 10.47, as compared to Highness Microelectronics IPO P/E ratio of 16.7.
| Goldline Pharmaceutical IPO | Highness Microelectronics IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 79.70 | 99.90 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 57.29 | 64.96 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 10.47 | 16.7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹41.28 Cr. | ₹61.96 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 35.83 | 47.09 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 38.45 | 42.09 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.50 | 0.74 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹4.11 | ₹7.19 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 27.37 | 47.09 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Goldline Pharmaceutical IPO Retail Individual Investors (RII) are offered 9,00,000 shares while in Highness Microelectronics IPO retail investors are offered 9,00,000 shares. Qualified Institutional Buyers (QIB) are offered 5,40,000 shares in Goldline Pharmaceutical IPO and 3,42,000 shares in Highness Microelectronics IPO.
| Goldline Pharmaceutical IPO | Highness Microelectronics IPO | |
|---|---|---|
| Anchor Investor Reservation | 7,32,000 shares | 5,11,200 shares |
| Market Maker Reservation | 1,38,000 shares | 91,200 shares |
| QIB | 5,40,000 shares | 3,42,000 shares |
| NII | 3,90,000 shares | 2,59,200 shares |
| RII | 9,00,000 shares | 6,02,400 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 25,62,000 shares | 17,14,800 shares |
Goldline Pharmaceutical IPO subscribed 600.53x in total, whereas Highness Microelectronics IPO subscribed 136.11x.
| Goldline Pharmaceutical IPO | Highness Microelectronics IPO | |
|---|---|---|
| QIB (times) | 180.22x | 81.95x |
| NII (times) | 1,662.04x | 362.12x |
| Big NII (times) | 2,010.60x | 437.22x |
| Small NII (times) | 980.75x | 211.92x |
| RII (times) | 881.15x | 185.11x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 600.53x | 136.11x |
